JPMorgan BetaBuilders U.S. Mid Cap Equity ETF
BBMCBATSJPMorgan ChaseEquity
As of Oct 16, 2026 close
- Assets (AUM)
- $2.03B
- Expense ratio
- 0.07%
- Dividend yield
- 1.15%
- Holdings
- 464
- 52-week range
- $99.77$130.07
- Volume (live)
- -
- Avg. volume (3M)
- 31.83K
BBMC ETF: JPMorgan BetaBuilders U.S. Mid Cap Equity ETF - Price, Holdings & Analysis
JPMorgan BetaBuilders U.S. Mid Cap Equity ETF Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
| Day's Range | $122.15 - $122.61 |
|---|---|
| 52-Week High | $130.07 |
| 52-Week Low | $99.77 |
| Open | $122.61 |
| Volume (last close) | 1.25K |
| Average Volume (3M) | 31.83K |
| 1 Day Change | +1.69% |
|---|---|
| 1 Month Change | −0.77% |
| 6 Month Change | +3.00% |
| YTD Change | +13.17% |
| 1 Year Change | +18.07% |
| 5 Year Change | +33.49% |
| Annual Dividend | $1.41 |
|---|---|
| Dividend Yield | 1.15% |
| Last Dividend Ex-Date | Sep 22, 2026 |
| Dividend Growth YoY | +2.70% |
| Years Dividend Growth | 5 |
| Assets (AUM) | $2.03B |
|---|---|
| Expense Ratio | 0.07% |
| Total Holdings | 464 |
| Inception Date | Apr 13, 2020 |
| 50-Day MA | $124.99 |
|---|---|
| 200-Day MA | $119.24 |
| RSI | 37.13 |
| Stochastic %K | 12.46 |
| Stochastic %D | 35.41 |
Source: Exchange price data and fund disclosures. Data as of Oct 16, 2026. Data sources and methodology
BBMC at a Glance
JPMorgan BetaBuilders U.S. Mid Cap Equity ETF (BBMC) is an equity ETF from JPMorgan Chase, launched in April 2020. It manages $2.03B in assets and charges a 0.07% expense ratio, about $7 a year per $10,000 invested.
As of its Oct 4, 2026 holdings, it holds 464 positions. The largest are Moderna, Inc. (MRNA, 1.48%), Natera, Inc. (NTRA, 1.23%) and Revolution Medicines, Inc. (RVMD, 0.92%). The top 10 holdings make up 8.1% of the fund. By sector it leans toward Industrials (20.1%), Technology (16.1%) and Healthcare (15.2%). 99.0% of assets are in the United States.
It pays distributions yielding 1.15% at the Oct 16, 2026 close, $1.41 per share over the trailing 12 months. As of the Oct 16, 2026 close, the share price is up 18.1% over one year and up 33.5% over five years (price change, excluding distributions).
Frequently Asked Questions About JPMorgan BetaBuilders U.S. Mid Cap Equity ETF
What is the current price of BBMC?
The latest BBMC price is $122.23 (Oct 16, 2026 close). The 52-week range is $99.77–$130.07. The share price is up 18.1% over the past year (price change, excluding distributions).
What is the expense ratio for BBMC?
BBMC's annual expense ratio is 0.07%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does BBMC pay dividends?
Yes, BBMC pays a 1.15% dividend yield (trailing 12 months, at the Oct 16, 2026 close). The most recent ex-dividend date was September 22, 2026. View full dividend history in the Dividends section.
What are the top holdings of BBMC?
As of Oct 4, 2026, BBMC's largest holdings are Moderna, Inc. (1.5%), Natera, Inc. (1.2%), Revolution Medicines, Inc. (0.9%) (combined weight: 3.6%). The fund holds 464 total positions. View the complete portfolio breakdown in the Holdings section.
How does BBMC compare to similar ETFs?
Compare BBMC (0.07% expense ratio, $2.03B AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.